Page 2,971«..1020..2,9702,9712,9722,973..2,9802,990..»

Cancer Patients’ Secondary Symptoms Need Attention: Study

Posted: September 11, 2011 at 4:08 pm

(HealthDay News) -- Many cancer patients with pain or depression also experience physical symptoms, such as fatigue, dry mouth and nausea, that can cause disability, a new study shows.

Doctors need to recognize and treat these symptoms in order to improve quality of life for cancer patients, said Dr. Kurt Kroenke, of the Richard Roudebush VA Medical Center, Indiana University, and Regenstrief Institute Inc. in Indianapolis, and colleagues.

They analyzed data from 405 cancer patients who had either pain or depression and found that all the patients had at least one of 22 physical symptoms examined in the study. More than half of patients reported 15 of the 22 symptoms.

The most common symptoms were fatigue (97.5 percent), difficulty sleeping (about 79 percent), pain in limbs or joints (78 percent), back pain (nearly 75 percent) and memory problems (72 percent).

The patients also reported an average of almost 17 disability days in the previous four weeks, including 5.7 days in bed and 11.2 days where they reduced their activity by 50 percent or more. Read more...

Cardiofy Heart Care Supplement

Source:
http://feeds.feedburner.com/integratedmedicine

Posted in Integrative Medicine | Comments Off on Cancer Patients’ Secondary Symptoms Need Attention: Study

International Stem Cell to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12

Posted: September 11, 2011 at 4:08 pm

International Stem Cell Corporation (OTCBB: ISCO) announced today that Kenneth Aldrich, Chairman, is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 12, 2011 at 11:40 a.m. Eastern (8:40 a.m. Pacific). The conference takes place at the Waldorf Astoria Hotel in New York City.
A webcast of the International Stem Cell Corporation presentation can be viewed live at http://www.wsw.com/webcast/rrshq20/isco. The presentation will be archived and available at the same link for 90 days. After the conference, a link to the presentation will also be posted to the ISCO website, http://www.intlstemcell.com.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
International Stem Cell Corporation
Kenneth C Aldrich, Chairman
760-940-6383
or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

Posted in Stem Cells, Stem Cell Therapy | Comments Off on International Stem Cell to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12

Video: The Promising Cells Presented by International Stem Cell Corporation

Posted: September 11, 2011 at 4:08 pm

Ken Aldrich of International Stem Cell Corporation (ISCO.OB) on the latest research involving stem cell technology utilizing unfertilized eggs, as a basis for cell generation with a goal toward organ transplants which are immune to rejection by the body...as well as other applications. Mr. Aldrich also discusses neurological applications focusing on reversing Parkinson's disease.
This corporate video was produced by Big Sky Productions Inc. (BGSI.OB).
Executive Producer: Ellis Martin
Producer and Creative Director, Narrator, Editor: Bob Lange

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

Posted in Stem Cells, Stem Cell Therapy | Comments Off on Video: The Promising Cells Presented by International Stem Cell Corporation

Cancer Patients' Secondary Symptoms Need Attention: Study

Posted: September 11, 2011 at 4:07 pm

(HealthDay News) -- Many cancer patients with pain or depression also experience physical symptoms, such as fatigue, dry mouth and nausea, that can cause disability, a new study shows.

Doctors need to recognize and treat these symptoms in order to improve quality of life for cancer patients, said Dr. Kurt Kroenke, of the Richard Roudebush VA Medical Center, Indiana University, and Regenstrief Institute Inc. in Indianapolis, and colleagues.

They analyzed data from 405 cancer patients who had either pain or depression and found that all the patients had at least one of 22 physical symptoms examined in the study. More than half of patients reported 15 of the 22 symptoms.

The most common symptoms were fatigue (97.5 percent), difficulty sleeping (about 79 percent), pain in limbs or joints (78 percent), back pain (nearly 75 percent) and memory problems (72 percent).

The patients also reported an average of almost 17 disability days in the previous four weeks, including 5.7 days in bed and 11.2 days where they reduced their activity by 50 percent or more. Read more...

Cardiofy Heart Care Supplement

Source:
http://feeds.feedburner.com/integratedmedicine

Posted in Integrative Medicine | Comments Off on Cancer Patients' Secondary Symptoms Need Attention: Study

International Stem Cell to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12

Posted: September 11, 2011 at 4:06 pm

International Stem Cell Corporation (OTCBB: ISCO) announced today that Kenneth Aldrich, Chairman, is scheduled to present at the Rodman & Renshaw Annual Global Investment Conference on Monday, September 12, 2011 at 11:40 a.m. Eastern (8:40 a.m. Pacific). The conference takes place at the Waldorf Astoria Hotel in New York City.
A webcast of the International Stem Cell Corporation presentation can be viewed live at http://www.wsw.com/webcast/rrshq20/isco. The presentation will be archived and available at the same link for 90 days. After the conference, a link to the presentation will also be posted to the ISCO website, http://www.intlstemcell.com.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
International Stem Cell Corporation
Kenneth C Aldrich, Chairman
760-940-6383
or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

Posted in Stem Cells, Stem Cell Therapy | Comments Off on International Stem Cell to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12

Video: The Promising Cells Presented by International Stem Cell Corporation

Posted: September 11, 2011 at 4:06 pm

Ken Aldrich of International Stem Cell Corporation (ISCO.OB) on the latest research involving stem cell technology utilizing unfertilized eggs, as a basis for cell generation with a goal toward organ transplants which are immune to rejection by the body...as well as other applications. Mr. Aldrich also discusses neurological applications focusing on reversing Parkinson's disease.
This corporate video was produced by Big Sky Productions Inc. (BGSI.OB).
Executive Producer: Ellis Martin
Producer and Creative Director, Narrator, Editor: Bob Lange

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

Posted in Stem Cells, Stem Cell Therapy | Comments Off on Video: The Promising Cells Presented by International Stem Cell Corporation

Spinal Cord Injury Patient after Stem Cell Treatment – Juan Carlos Murillo

Posted: September 11, 2011 at 3:36 am

Juan Carlos Murillo - Spinal Cord Injury Patient after treatment

Visit link:
Spinal Cord Injury Patient after Stem Cell Treatment - Juan Carlos Murillo

Posted in Stem Cell Treatments | Comments Off on Spinal Cord Injury Patient after Stem Cell Treatment – Juan Carlos Murillo

Stem Cell Research: Huntington's Disease

Posted: September 10, 2011 at 1:12 pm

Huntington's disease is an inherited neurodegenerative disorder that typically strikes in a person's thirties and leads to death about 10 to 15 years later. No effective therapy exists for the disease. Jan Nolta, director of the UC Davis Stem Cell Program and Institute for Regenerative Cures, has a CIRM Early Translational Award to develop stem cell-based therapies for Huntington's disease.

Read the original:
Stem Cell Research: Huntington's Disease

Posted in Cell Medicine | Comments Off on Stem Cell Research: Huntington's Disease

Regenerative Medicine: Pathways to Cure – Version 2.0

Posted: September 8, 2011 at 7:11 am

The Alliance for Medical Research is pleased to present a new video explaining the benefits of Stem Cell Research.

Go here to see the original:
Regenerative Medicine: Pathways to Cure - Version 2.0

Posted in Cell Medicine | Comments Off on Regenerative Medicine: Pathways to Cure – Version 2.0

Post Stem Cell Therapy Testimony of Cerebral Palsy

Posted: September 5, 2011 at 6:36 pm

Stem cell therapy done at neurogen brain and spine institute pvt ltd. Tell: +91 9920 200 400 , 022 25281610 , 022 25283706

Read the rest here:
Post Stem Cell Therapy Testimony of Cerebral Palsy

Posted in Stem Cell Treatments | Comments Off on Post Stem Cell Therapy Testimony of Cerebral Palsy

Page 2,971«..1020..2,9702,9712,9722,973..2,9802,990..»